|
Disease-free and overall survival outcomes for localized RCC patients by disease stage. |
|
|
Consulting or Advisory Role - AVEO; Calithera Biosciences; Eisai; Exelixis; Merck Sharp & Dohme; Pfizer; Roche/Genentech |
Expert Testimony - Lilly (I) |
|
|
Employment - Merck; Otsuka (I) |
|
|
|
Research Funding - Merck (Inst) |
|
|
|
Stock and Other Ownership Interests - Merck |
|
|
|
Research Funding - Merck (Inst) |
|
|
Stock and Other Ownership Interests - Merck |
Patents, Royalties, Other Intellectual Property - Patent pending as a Merck emplyee |
|
|
|
Research Funding - Merck (Inst) |
|
|
|
Research Funding - Merck (Inst) |
|
|
No Relationships to Disclose |